Stock options vest over a prescribed service period and are approved by the Company's board of directors on an award-by-award basis. Options have a prescribed service period generally lasting up to four years, with certain options vesting immediately upon issuance. Upon the exercise of any stock options, the Company issues shares to the award holder from the pool of authorized but unissued common shares.

There were no options granted for the three months ended March 31, 2026 and March 31, 2025. Detail of the number of stock options outstanding for the three months ended March 31, 2026 under the Company's amended 2018 Long-Term Incentive Plan (the "2018 Plan") is as follows:


	Number of Options	Weighted- Average Exercise Price per Option		Weighted- Average Remaining Contract Term (in years)	Aggregate Intrinsic Value
Outstanding as of December 31, 2025	1,967,426	$	1.04	6.57	$	28
Granted	—	—
Exercised	—	—
Forfeited (and expired)	(42,614)	1.20
Outstanding as of March 31, 2026	1,924,812	$	1.04	6.33	$	451

Exercisable/vested as of March 31, 2026	1,729,638	$	1.12	6.24	$	370

The Company has issued time-based restricted share units to certain employees as permitted under the 2018 Plan. The restricted share units granted vest in accordance with the board-approved agreement, typically over equal installments up to four years. Upon vesting, one share of the Company's common shares is issued for each restricted share unit awarded. The fair value of each restricted share unit granted is equal to the market price of the Company's shares at the date of the grant. The fair value of shares vested during the three months ended March 31, 2026 was $77. There were no shares vested during the three months ended March 31, 2025.


	Number of Shares	Weighted-Average Grant Date Fair Value
Outstanding as of December 31, 2025	4,084,117	$	0.18
Granted	—	$	—
Forfeited	(176,267)	$	0.09
Vested	(263,812)	$	0.29
Shares withheld upon vesting	(111,188)	$	0.29
Outstanding as of March 31, 2026	3,532,850	$	0.18

Share-based compensation expense for all equity arrangements for the three months ended March 31, 2026 and March 31, 2025 was $151 and $187, respectively, included in selling, general and administrative expense in the condensed consolidated statements of operations. As of March 31, 2026, $3,268 of total unrecognized share-based compensation expense related to unvested options granted to employees is expected to be recognized over a weighted-average period of 2.62 years.